Considering the breast cancer cell line MDA‐MB‐231 (expressing high endogenous levels of Hsp90), a range of compounds exhibited significant inhibition of cell viability at 10 μM treatment concentration. This evidence concerns the gene HSP90AB1 and breast carcinoma.